Onkure Therapeutics, Inc. · NASDAQ:OKUR
StepStone Group LP reported a 6.60% stake in Onkure Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 7, 2026
StepStone Group LP reported a 6.60% stake in Onkure Therapeutics, Inc., 2,660,612 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G).
- Stake
- 6.60%
- Shares
- 2,660,612
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| StepStone Group LP | 6.60% | 2,660,612 |
| StepStone Master G, L.P. | 6.60% | 2,660,612 |
| StepStone VC MI-G GP, LLC | 6.60% | 2,660,612 |
Source
Related
- Onkure Therapeutics, Inc.
- StepStone Group LP
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · Aug 14, 2026